Literature DB >> 14686909

Disruption of prepulse inhibition in mice lacking mGluR1.

S A Brody1, F Conquet, M A Geyer.   

Abstract

Sensorimotor gating, measured by prepulse inhibition of the startle response (PPI), is a cross-species form of information processing that is deficient in patients with schizophrenia and is widely used as a model to study the neurobiology of this disorder. The eight known metabotropic glutamate receptors (mGluRs) are divided into three groups on the basis of sequence homology and pharmacological properties. Group I consists of mGluR5 and mGluR1, both of which are coupled positively to phospholipase C. Mice lacking mGluR5 exhibit a deficit in PPI. Like mGluR5, mGluR1 is located in regions that are involved in the modulation of PPI. To test the hypothesis that mGluR1 is involved in the modulation of PPI we assessed PPI in mGluR1 knockout (KO) mice. Littermate mGluR1 wild-type and KO mice were tested at multiple ages in a standard PPI paradigm containing a 65 dB background, 120 dB pulses and prepulses of 69, 73 and 77 dB. At all ages tested, mGluR1 KO mice exhibited a significant PPI deficit. The PPI deficit of the mGluR1 KO mice was not further exaggerated by administration of the N-methyl-d-aspartate antagonist phencyclidine nor was it reversed by administration of the dopamine antagonist raclopride (3.0 mg/kg). The PPI deficit of the mGluR1 KO mice was, however, ameliorated by administration of the mood stabilizer lamotrigine (27 mg/kg base equivalent weight), though increases in PPI were also seen with lamotrigine in the wild-type mice. Thus, both group I metabotropic glutamate receptors are involved in the regulation of PPI in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14686909     DOI: 10.1111/j.1460-9568.2003.03073.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  37 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

3.  Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.

Authors:  Paul D Shilling; Richard L Saint Marie; Jody M Shoemaker; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

4.  Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Sheryl S Moy; Jeffery A Lieberman; Beverly H Koller
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

5.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

6.  Presynaptic Inhibition Selectively Gates Auditory Transmission to the Brainstem Startle Circuit.

Authors:  Kathryn M Tabor; Trevor S Smith; Mary Brown; Sadie A Bergeron; Kevin L Briggman; Harold A Burgess
Journal:  Curr Biol       Date:  2018-08-02       Impact factor: 10.834

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 8.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 9.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

10.  Variations in postnatal maternal care and the epigenetic regulation of metabotropic glutamate receptor 1 expression and hippocampal function in the rat.

Authors:  Rosemary C Bagot; Tie-Yuan Zhang; Xianglan Wen; Thi Thu Thao Nguyen; Huy-Binh Nguyen; Josie Diorio; Tak Pan Wong; Michael J Meaney
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.